About pimecrolimus
Topical calcineurin inhibitor
Used for
- Short-term and intermittent treatment of mild to moderate atopic dermatitis (eczema) in adults and children aged 2 years and older.
Usual adult dose
Apply a thin layer to affected skin twice daily until clear.
Usual dose in children
For ages 2 years and older: apply a thin layer to affected skin twice daily until clear.
Common side effects
- Burning, warmth, or stinging at the application site
- Skin irritation, redness, or itching
- Headache or common cold symptoms
Important warnings
- Not for children under 2 years.
- Avoid continuous long-term use; safety beyond one year is not established.
- Avoid use on infected skin; treat infections before starting.
- Rare reports of cancer exist; a causal link has not been established.
Pregnancy
Human pregnancy data are limited; use only when clearly needed.
Breastfeeding
It is unknown whether it passes into breast milk; avoid applying to the breast before nursing.
Interactions
- No established clinically important interactions with topical medicines.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.